Additionally, in a mouse glioma model, Gal-1-deficient tumor cells could be eradicated by host NK cells even before the initiation of an anti-tumor T cell response, suggesting that glioma cell-derived Gal-1 suppresses NK cell immune surveillance [171]. Here, GAL is linked to central nervous system cancer.